Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123470372 | 12347037 | 2 | F | 20151201 | 20160728 | 20160509 | 20160802 | PER | US-CELGENEUS-USA-2015124640 | CELGENE | 68.56 | YR | F | Y | 0.00000 | 20160802 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123470372 | 12347037 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | A0480F | 21880 | 15 | MG | CAPSULES | QD | ||||
123470372 | 12347037 | 2 | SS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | A0480F | 21880 | 10 | MG | CAPSULES | QD | ||||
123470372 | 12347037 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | U | U | 0 | INJECTION FOR INFUSION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123470372 | 12347037 | 1 | Plasma cell myeloma |
123470372 | 12347037 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123470372 | 12347037 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123470372 | 12347037 | Abdominal pain | |
123470372 | 12347037 | Anaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123470372 | 12347037 | 1 | 20151123 | 20160314 | 0 | |
123470372 | 12347037 | 2 | 20160314 | 0 |